Paul Touhey is CEO and President of Fujirebio Diagnostics, Inc (FDI), one of the world’s premier cancer diagnostics company. Touhey brings more than 25 years of industry experience to the position, in which he is responsible for the company’s growth in the competitive in vitro diagnostics industry. Touhey is also a member of the Board of Directors of Fuijrebio Inc, the Tokyo-based parent of FDI. Prior to joining FDI, he held various positions with Johnson & Johnson. A past Chairman and current member of the Board of the Medical Device Manufacturers Association (MDMA), Touhey is a graduate of Temple University. He is a third generation Irish American, with roots in County Cork. He is married with two children and four grandchildren, and resides in Royersford, Pennsylvania.   
 

Return to Life Science 50